Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
20-Jun-2018Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME studyAnzueto, AR; Kostikas, K; Mezzi, K; Shen, S; Larbig, M, et al
9-Aug-2018Single-inhaler triple versus dual therapy in patients with COPDWedzicha, JA; Banerji, D; Kostikas, K
10-Apr-2018Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME studyVogelmeier, CF; Chapman, KR; Miravitlles, M; Roche, N; Vestbo, J, et al
1-Aug-2018Long-term triple therapy de-escalation to indacaterol/glycopyrronium in COPD patients (SUNSET): a randomized, double-blind, triple-dummy clinical trialChapman, KR; Hurst, JR; Frent, S; Larbig, M; Fogel, R, et al
15-Sep-2018Patient reported outcomes for the detection, quantification and evaluation of chronic obstructive pulmonary disease exacerbationsMackay, AJ; Kostikas, K; Murray, L; Martinez, FJ; Miravitlles, M, et al